Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You let us down when your hyping failed and SequestOx failed !!!!!!!!!!!!!!!
A $0.25 Mikah buyout is a FAT Premium ..............
Would Elite's Board of Directors accept a takeover bid from Mikah for $0.25 per share ????????????
IB_🤴🏻
HGlis is in your village today.
Give him a big hug
ELTP
I’m adding too, thx for 5he help.
Locked $ Loaded
$5.00 stock on sell for $0.14 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Would Elite's Board of Directors accept a takeover bid from Mikah for $0.25 per share ????????????
Hummmm,
IB_🤴🏻
Elite's Naltrexone is looking good too.
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Naltrexone%20Hydrochloride%20Tablet&st=c&tab=tabs-1
I don't think they have ever been in shortage
looking good, Right on schedule for Elite, on the shortage page, 4/15
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet&st=c&tab=tabs-1
it's been about every 15 days, they get a new update, since they started building the new plant
just down the street.
Also, I think they get inspected every time they get a new ANDA
Would it not matter the most, how many times the SEC has been told that ???????????????????
IB_🤴🏻
Hi team.
I am close to goat land this week for work.
Won’t write much
Glta.
Mikah ? They can’t buy Elite They don’t exist anymore so we were told 4 times
Not the first time. Someone did it couple months back. I rarely look at yahoo board anymore.
Yeah, it didn’t seem like it would be HGilS. I wonder who would have made a fake ID using his name then?
What do you think Elites Board of Directors would say to a $0.25 per share offer, by: Mikah ....................
Hummm,
IB_🤴🏻
Clearly a fake. Very sad.
That would make a lot of millionaires but we are after multimillions
Do the math:
Uhh $0.25 from Mikah for ELTP would be a premium which is UP !!!!!!!!!!!!!!
Math is hard for some,
IB_🤴🏻
Ok, that really is odd. I got almost the exact same message. Anyone else get this message?
So this is really weird. I almost feel bad. An account named HGilS messaged me on yahoo and said, “Can you please stop being mean to me and take me off of ignore on ihub? My boss treats me horrible and refuses to pay me if I don’t get enough responses to my posts. I don’t want to do these things, it’s just what I have to do in my country. Please, I need another goat.”
HGilS this wasn’t you was it?
Drop it to .10 cents for me! You got this little buddy!
I’m averaging UP since the HammerBottom Buy Blitz
22 months to Early Retirement
Locked and Load3d
ELTP is a golden parachute!
Thanks ib
Take it down.
I have cash coming soon
Correct. PR was due to the materiality expected. Nasrat mentioned that in a prior call. It’s not our news to share unless we expect a big financial impact to Elite.
Here' the good news after a little more research since 210 M seemed pretty cheap for a major drug company.
The Evanstad family has privately held Upsher since 1919. On 4/28 17 they sold the Generic Pharmaceutical business for 1.05 Billion !! to Sawai Pharma who bought the balance this year.
Congratulations to the Chairman Ken Evenstad and his son and CEO Mark Evensted for banking a cool billion. I hope your family has used the wealth wisely.
A 1 billion market cap for elite sounds about right before the 3 needle movers kick in. That translates to around .70 a share for Elite holders.
Following your logic we should not have received a PR for the Prasco launch
---------------------------------------------------
Not our product to launch. We are only a contract mfr.
Because that is how lottery club dreamers think.
And that’s why Elite is worth 14 cents
Upsher-Smith has 550 employees (10 times Elite's staff) its revenue per employees as $763.000Its peak revenue was $420 Million in 2023 ( 9-10 times elite's expected 2023 revenues to be announced in June).
They manufacture more than 59 drugs in the US and apparently also manufacture for Europe and Asia since they were bought by Sawai Group Holdings.
Good stuff imanjen13.
Thanks
$ELTP baby~!
Elite at $0.14 is way undervalued right now making the market cap a joke as it stands.
The "market" is way too corrupt to make accurate valuations of Companys, one of which being Elite Pharmaceuticals.
What does Elite have to do to get a fair assessment~? Current share price is bunk based on current revenues alone.
After being CFP for how many years, increasing revenues each quarter, drugs currently being manufactured on the shortage list, new ANDAs in the pipeline (needle movers), Elite now with their own BRANDED products, and partnerships with other Pharmaceutical Companies............. the share price is at $0.14~?
If it seems like the share price is being suppressed, the share price IS being suppressed. Many tickers are experiencing the same thing, but Elite has the better balance sheet for sure~! Go figure~!
Blame the DTCC CNS program for this crap. That's where the bulk of these shares come from in daily trades.
Oh, forget ORTEX and FINRA data. Total fiction. Not accurate by any stretch when shorted shares are labeled LONG. They use sham resets, flex options, buy rights, and married puts ALONG with labeling short shares as long.
It's all right there in the Overstock lawsuit.
Just about every stock out there is manipulated this way.
Didn't JP Morgan just get caught labeling Short shares as Long~? Signed an Acceptance Waiver and Consent, got the felony cancelled out as though it never happened and paid a small fine that can be used as a tax write off~?
This was a couple of months ago~? Wash, rinse, dry, repeat....... oh sorry we mislabeled them, won't happen again. Right~!
And the beat goes on~!
$ELTP baby~!
Hey, do you all think that Elites Board of Directors would approve a buyout offer of $0.25 cent per share from Mikah Pharma ???????????????
IB_🤴🏻
How many drugs did they have ?
Why would you add it to the buyout price when the contract would end around then and has no future cash flow benefit? Doesn’t sound like Nasrat’s is expecting the agreement to be extended. If things change, only then it would make sense to be included in forward looking DCF analyses for a buyout.
Pyros was in a trademark dispute over the Vigapoder name which was not resolved until January 24, 2024 when Upsher decided to not dispute the trademark name which was similar to their product Vigadrone. Coincidentally that was around the same time they were bought out by Bora.
They could not launch and use the name until that was decided.
Nasrat may have been more upset that he sold the product for a song worth less than the cost for the R&D and filing. Elite was probably desperate at the time as was Sungen when they had to sell their rights to Adderall to MIkah for a steal due to serious financial hardship.
That being said, Pyros may extend the manufacturing contract before it expires.
ADD it to the BuyOut price
Apparently Nasrat was upset that the orders did not start for a year plus. But now the agreement is on - until end of November 2025 - that should be close to BO day
Elite sold its rights to its approved Vigabatrin powder and executed a contract with Pyros for the manufacturing and packaging of the product for commercial sale for a three year period. Consequently that supply and packaging agreement ends in November 2025. See 8k filed 11/28/22.
Just keep buying...just keep buying...buy, buy, buy!!
THX, now I remember
Elite has a current Market cap of 142M with a .14 cent price. Upsher-Smith a Corporation in business since 1919 was sold for a total of $210 M. Obviously I am not saying Vigabatrin is worth $210.
This stock is dead in the water and will be till July cc
From June 30 2023 Teleconference - found this in transcript:
Please provide an update on the Pyros genetic vigabatrin launch? We are nearing one year into three year deal with zero revenues
generated thus far. We sold Pyros the product. It is theirs, okay? We are contact manufacturers. When they ask us to manufacture it, we will manufacture it at a cost plus, but that's about it. This is not a product that we intend to discuss. I wish them success. We will support them in any way we can to succeed, but this is their product now and we will contact manufacturers for a couple of years for them and we'll move on, okay.
------------
If I am not wrong, we had already Kirko on board - so we manufacture it if they ask us to...
look, there is no Elite on these pages, sabril or any other name
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
nor in the Orange book,
who ever makes the Powder for Pyros is a secret
and they can not tell you , it will not be a secret any more
I can not tell you
when we were in Egypt, they told us the secrets of the Pirimids too
That’s the total market, not our market share.
Not our product to launch. We are only a contract mfr.
Are you saying a Vigabatrin approval alone is worth $210 million dollars? Wouldn't that put us at around 20 cents as a valuation on that drug alone?
Thanks imangin, for the leg work, if you go to the Orange book, Pyros only has one drug,
and all the rest don't say peep about Elite, Sabril or all the others are not on Elite,
did my DD.
If I remember , when Kirko was hired, Elite dropped the drug.
my opinion,
he didn't want to sell any drug that could cause blindnes or death, so Narat dropped it,
if you look at the bottom of the pages, it says Manufacterd , by nobody, for Pyros
nobody want's to get sued
not worth it
cant trace it
Followers
|
1024
|
Posters
|
|
Posts (Today)
|
27
|
Posts (Total)
|
410829
|
Created
|
03/24/09
|
Type
|
Free
|
Moderators jimr1717 mrwrn2010 NASDAQ2020 IB_ namtae Dr JoeBarducci |
Senior Moderator: IB_
Posted: 7/02/2024
________________________________________________________________________________________________________________
Elite Pharmaceuticals, Inc. |
Website | Location | Employees | Facility | CEO |
www.elitepharma.com | Northvale, New Jersey | 64 | 85,000 sq ft | Nasrat Hakim |
Products & Pipeline | ||||
Drug | Market Size | Status | Competitors | Marketed By |
Adderall IR | 389.8 M | On Market | 15 | Elite |
Adderall XR | 1.56 B | On Market | 10 | Elite & Prasco |
Dantrolene | 6.3 M | On Market | 2 | Elite |
Isradipine | 5.5 M | On Market | 1 | Elite |
Loxapine | 5 M | On Market | 2 | Elite |
Phendimetrazine | 4.5 M | On Market | 4 | Elite |
Trimipramine | 2 M | On Market | 1 | Elite |
Naltrexone | 16 M | On Market | 5 | Precision Dose |
Phentermine Capsules | 7.5 M | On Market | 6 | Precision Dose |
Phentermine Tablets | 40 M | On Market | 8 | Precision Dose |
Vigabatrin | 233.7 M | On Market | 13 | Pyros |
Doxycycline | 85 M | Approved (Discontinued) | 9 | ---------- |
Tylenol with Codeine | 47 M | On Market | 5 | Elite |
Dopamine Agonist | 12 M | Filed with FDA - 22 Dec 2022 | ---------- | ---------- |
Methotrexate | 63.4M | On Market | 8 | Elite |
Percocet | 500 M | Approved in Launch Queue | 14 | ---------- |
Norco | 477 M | Approved in Launch Queue | 12 | ---------- |
Methadone | 30 M | Approved in Launch Queue | 8 | ---------- |
OxyContin | 720 M | Filed with FDA - 17 Aug 2023 | ??? | ---------- |
Vyvanse | 5.10 B | Filed with FDA - 21 Dec 2023 | 11 | ---------- |
Concerta | 1.16 B | In Development (Final Stages) | 8 | ---------- |
Financials | ||||
Fiscal Year | Revenue | Change | Net Income | Change |
2019 | 7,568,508 | ---------- | (9,279,321) | ---------- |
2020 | 17,994,639 | +137.76% | (2,240,351) | +75.86% |
2021 | 25,380,749 | +41.05% | 5,088,421 | +327.13% |
2022 | 32,262,117 | +27.11% | 8,898,245 | +74.87% |
2023 | 34,155,114 | +5.87% | 3,561,846 | -59.97% |
2024 | 56,625,128 | +65.79% | 20,108,631 | +464.56% |
2025 Q-1 | 18,803,063 | +109.39% | 3,864,056 | +144.00% |
2025 Q-2 | ||||
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |